Answers are grounded in this paper and cite their sources.
Lysine acetylation is an epigenetic mark that is principally recognized by bromodomains, and recently structurally diverse YEATS domains also emerged as readers of lysine acetyl/acylations. Here we present a crystallography-based strategy and the discovery of fragments binding to the ENL YEATS domain, a potential drug target. Crystal structures combined with synthetic efforts led to the identification of a submicromolar binder, providing first starting points for the development of chemical probes for this reader domain family.
No takes yet. Share an insight, caveat, or question.
Heidenreich et al. (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: